Regulators emphasize the need for data harmonization,
quality assurance, and standardized methods when
using real world evidence (RWE).

While common protocols align study design, differences in coding systems, data availability, and local implementation often lead to inconsistent results across countries unrelated to differences in healthcare systems.

Key benefits of common programming and centralized analysis include:

    • Reduced statistical heterogeneity through pre-emptive analytic harmonization

    • Increased confidence in pooled estimates, driving clearer
      regulatory messaging

    • Accelerated study timelines, as programming bottlenecks and local validation cycles are minimized

    • Facilitated regulatory dialogue, with structured outputs that anticipate scientific scrutiny

    • Interpretation between-country differences meaningfully rather
      than explain them away post hoc

We invite you to put our data to the test. Email us at contact@lumanity.com to discuss your research needs.

Download our one-pager

Complete the form to download our one-pager on common programming and centralized analysis

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Sign me up to receive regular insights from Lumanity
By selecting this box, I consent to receive Lumanity marketing communications by email.